Relaxation once only welcomed time-proven pursuits like meditation or a warm bath. But in 2025, more and more will opt for ...

Amgen and AstraZeneca today announced that the U.S. Food and Drug Administration (FDA) approved TEZSPIRE® (tezepelumab-ekko) for the add-on maintenance treatment of inadequately controlled chronic ...

Eli Lilly and Company today announced results from the primary overall survival (OS) analysis of the Phase 3 monarchE trial ...

Digital health strategies in India emphasize legible prescriptions, electronic records, and telemedicine, improving patient ...

Experience a 72-hour Baker Act hold. From intake to diagnosis and discharge. What really happens when you're Baker Acted in ...

TNX-801 is a live virus vaccine investigational candidate, designed to provide durable protection against mpox and smallpoxTNX-801 demonstrated ...